Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation.
about
Sacral nerve stimulation for faecal incontinence and constipation in adultsConsensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment)Dyssynergic defecation and biofeedback therapyGuidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised EditionA critical appraisal of lubiprostone in the treatment of chronic constipation in the elderlyTreatment for constipation: new and old pharmacological strategiesNovel therapies for constipationReview article: the treatment of functional abdominal bloating and distension.Persistent constipation and abdominal adverse events with newer treatments for constipation.Electro-acupuncture to prevent prolonged postoperative ileus: a randomized clinical trial.Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation.Understanding and treating refractory constipation.Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipationManagement of chronic constipation in adults.Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents.SYMPOSIUM REPORT: An Evidence-Based Approach to IBS and CIC: Applying New Advances to Daily Practice: A Review of an Adjunct Clinical Symposium of the American College of Gastroenterology Meeting October 16, 2016 • Las Vegas, Nevada.Recent advances in pharmacological treatment of irritable bowel syndrome.Update on the management of constipation in the elderly: new treatment optionsEfficacy and safety of lubiprostone in patients with chronic constipation.Prucalopride for constipation.Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndromeCurrent and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation.Lubiprostone in constipation: clinical evidence and place in therapy.Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipationScintigraphic biomarkers for colonic dysmotility.A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosaPrucalopride: safety, efficacy and potential applications.Epidemiology and management of chronic constipation in elderly patients.Chronic constipation in the elderly: a primer for the gastroenterologistAdvancing treatment options for chronic idiopathic constipation.Advances in IBS 2016: A Review of Current and Emerging Data.Effective Constipation Treatment Changes More Than Bowel Frequency: A Systematic Review and Meta-Analysis.Current and emerging therapies for the management of functional gastrointestinal disorders.Lubiprostone: a novel treatment for chronic constipation.
P2860
Q24187787-E8B4DE93-4994-4D43-ACFB-7ED4B454B209Q24633140-9D52BE40-37EA-440A-ABEA-18940EDD5EADQ24646884-6B75DC6B-299C-4579-A1C5-8D31860A66FAQ26745952-315CC543-3CE3-4A52-BBEF-21B4806EDD60Q26824999-5B2F18FA-0C4C-4FF1-8C2E-9CC8E635A993Q27027346-09918EFF-9185-429F-A030-CFC56BD6EF97Q27027873-4C074AC4-C079-4655-B60C-9A3D8B310C3FQ33450132-2893D4CB-7903-4DF8-974D-1411F3E2D15BQ33468562-B3FBF28E-71A9-4A86-AC85-22F826E3E4B3Q33564922-B0BC7DD1-FE72-47EE-B741-561E336F0BDAQ33586854-9CD5643F-F2CB-43AC-8D95-3EC4D2ABB8F0Q33621273-619D75C7-8AA3-4B22-8C14-6A70CFC93D3EQ33695487-599911C9-2BC3-4911-9359-A0902FE0C1A8Q33731980-9EBB0640-6331-460A-8A31-5F30AC5E6FCDQ33854983-DE145D2D-881B-4198-84AD-8FC6D267C227Q33865075-ACD964EE-DFBF-4CAD-91F8-BB0A9E0C1690Q33958853-2B39DE15-1524-4C0C-ACEC-D0A229697469Q34060462-88690B3E-0889-4B18-8186-DD38779FCC10Q34088270-B8707070-26F6-4735-97B2-99F7348439F0Q34094831-2FDADD16-571A-4A33-B0AB-D7024CD92BC9Q34323319-8618AEE1-D8C8-4114-BB51-50A23EC77AE8Q34345704-77A59AA5-0327-43B5-9A96-062820DF3B2AQ34478089-D4A97994-9016-45DA-9DCD-3207ABE09C98Q34522966-43815226-7A89-4A73-A1BD-FE28B81ED9F1Q34805216-0DAAE2AA-D2F6-41F7-AA48-024B8759B091Q35018460-5DBAFE32-7DF3-490F-9A11-8A983C61CBCBQ35026383-9420C8C0-D193-4E22-9583-D1B3794F4385Q35091370-FB076AC4-34B1-416B-B4BE-0224DE54EEC0Q35204780-3286D09C-2FD6-4404-BC4A-77808C5173CBQ35384517-D8431218-5B08-46D9-A7BA-D8026055AC78Q35583262-43109A9B-C525-449C-AF4A-A0651637419FQ35664952-2F830817-039C-4A1B-97E1-5404C1E598D6Q35688594-AF7F66ED-EE49-469F-A814-0D1FCE9C779DQ35694427-B0F6A936-CDE7-4129-93D8-6C880925DB05Q35807577-A701DDE3-D6AD-45CA-AC8F-47567D4A1E0CQ35858864-DC7C53A6-4AF6-4605-951D-F80F5EEDA017Q36245061-6F233979-FFE8-4B29-8004-32C96B65A645Q36426025-DCF62658-625A-4B71-ABA8-DFDE41FE1C54Q36443725-5E88AF02-DED6-4E28-89EA-1F81ADE6566AQ36897461-3B6E0B4E-6186-4F7C-B3D2-5526063DAC0E
P2860
Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Multicenter, 4-week, double-bl ...... nts with chronic constipation.
@en
Multicenter, 4-week, double-bl ...... nts with chronic constipation.
@nl
type
label
Multicenter, 4-week, double-bl ...... nts with chronic constipation.
@en
Multicenter, 4-week, double-bl ...... nts with chronic constipation.
@nl
prefLabel
Multicenter, 4-week, double-bl ...... nts with chronic constipation.
@en
Multicenter, 4-week, double-bl ...... nts with chronic constipation.
@nl
P2093
P2860
P1476
Multicenter, 4-week, double-bl ...... nts with chronic constipation.
@en
P2093
Dan Morton
John F Johanson
Joseph Geenen
Ryuji Ueno
P2860
P304
P356
10.1111/J.1572-0241.2007.01524.X
P407
P577
2007-10-04T00:00:00Z